Rheumatoid arthritis – symptoms, diagnosis, treatment
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.035Keywords
rheumatoid arthritis, metotrexatAbstract
Rheumatoid arthritis is a systemic autoimmune disease of connective tissue of unknown etiology. Specific for it is the involvement of symmetrically small and medium-sized joints, leading to degradation of their structure, stiffening and muscle contractures. It is also characterized by extra-articular and generalized symptoms, such as fatigue, low-grade fever and sweating. It can occur with or without elevated RF and / or ACPA antibodies, causes disability and contributes to premature death. Drugs for this disease can be categorized into disease-modifying drugs as well as glucocorticosteroids and non-steroidal anti-inflammatory drugs. The first-line drug is methotrexate. In case of ineffectiveness of the treatment, biological treatment can be started.
References
Ramiro S, Sepriano A, Chatzidionysiou K, et al. EULAR recommendations
for the management of rheumatoid arthritis with synthetic
and biological disease-modifying antirheumatic drugs: 2016 update.
Ann Rheum Dis. 2017; 76(6): 960–977, doi: 10.1136/annrheumdis-2016-210715,
indexed in Pubmed: 28264816
A. Jura-Półtorak, K. Olczyk, Diagnostyka i ocena aktywności reumatoidalnego zapalenia stawów . Diagnostyka laboratoryjna 2011, nr 4, s. 431.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS i wsp.
The American Rheumatism Association 1987 revised criteria
for the classifi cation of rheumatoid arthritis. ArthritiscRheum
;31:315–324
Felis-Giemza, A. (2017). Strategia leczenia chorych na reumatoidalne zapalenie stawów z uwzględnieniem obecności czynników „złej prognozy”. Varia Medica, 1(1), 92-98.
Leczenie reumatoidalnego zapalenia stawów syntetycznymi i biologicznymi lekami modyfikującymi przebieg choroby - aktualizacja wytycznych EULAR 2013 r. - Wytyczne - Reumatologi..., www.mp.pl [dostęp 2017-11-26] (pol.).
Interna Szczeklika 2021, Andrzej Szczeklik, Piotr Gajewski, Tabela 16.1-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Dominik Machaj, Alicja Płaczek, Katarzyna Cyboran, Agnieszka Siedlak, Filip Białas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 471
Number of citations: 0